Schonfeld Strategic Advisors’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-106,423
Closed -$1.06M 2527
2021
Q3
$1.06M Buy
106,423
+19,533
+22% +$194K 0.01% 860
2021
Q2
$858K Buy
+86,890
New +$858K 0.01% 941